Market Overview

Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson

Related VRX
Benzinga's M&A Chatter for Tuesday November 18, 2014
Bill Ackman Says He Supports The Allergan-Actavis Deal And CEO Brent Saunders
Deal Frenzy: 2014 Sees Record M&A Volume (Fox Business)
Related AGN
#PreMarket Primer: Friday, November 21: Immigration Reform Could Have Lasting Impact In More Ways Than One
Can The Uptrend Continue For Allergan?
Deal Frenzy: 2014 Sees Record M&A Volume (Fox Business)

Allergan Inc. (NYSE: AGN) shares bumped up more than 2 percent on a rumor that Hedge fund Paulson & Co. acquiredsix6 million shares.

The report by Reuters said Paulson backs Valeant Pharmaceuticals (NYSE: VRX) in its proxy battle to acquire Allergan and the new stake puts Paulson among Allergan's top holders.

Valeant needs support from 25 percent of Allergan's holders in order to call a special shareholder meeting to vote on its $53 billion bid.

Allergan has called the offer "grossly inadequate."

With a current market capitalization of about $50.3 billion, Allergan traded recently at $69.02, up 2.2 percent.

Posted-In: News Rumors

 

Related Articles (AGN + VRX)

Around the Web, We're Loving...

Get Benzinga's Newsletters